Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000569180 | SCV000664446 | pathogenic | Hereditary cancer-predisposing syndrome | 2017-08-07 | criteria provided, single submitter | clinical testing | The c.77_80delTTCCinsAAGAACGT pathogenic mutation, located in coding exon 2 of the TP53 gene, results from the deletion of 4 nucleotides and insertion of 8 nucleotides causing a translational frameshift with a predicted alternate stop codon (p.L26Qfs*4). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Laboratory for Molecular Medicine, |
RCV000036535 | SCV000060190 | likely pathogenic | Li-Fraumeni syndrome | 2009-02-05 | no assertion criteria provided | clinical testing |